DISCOUNT DILEMMA
PERSONAL FINANCE | ADVICE
When you go to the pharmacy, you might be offered a coupon on your prescription drugs. While it may sound like a great deal, the decision to accept it is complicated. Even as prescription drug costs rise, patients with commercial insurance slowed their use of manufacturer-sponsored drug coupons in recent years, according to a study the
These are not the same as discount card services from companies like
Drug manufacturers distribute copay coupon cards to consumers to keep their drugs competitive by offering patients short-term savings. Consumers pay less out-of-pocket, often for brand-name drugs. This encourages patients to use the brand-name version, even when a cheaper, generic version might be available.
Some insurers say this unfairly puts them on the hook for pricier drugs. They say monthly premiums are higher as a result, punishing consumers and patients.
Should you use manufacturer-sponsored drug coupons? It depends.
1 What if you don't have insurance?
If you are uninsured, using a coupon can be a great way to save money, especially if there is no generic version of the drug.
TrumpRx is a new federally funded initiative that acts as a prescription drug coupon dashboard for patients. Some of the coupons come from manufacturers, while others do not; not every drug has a coupon offer.
It is important to note drug coupons have limitations and guidelines, and they don't last forever.
2 What if you have insurance?
If the drug isn't covered by your commercial health insurance plan or if you intend to pay cash, the coupon may be the way to go.
Insurance coverage varies for certain kinds of drugs, such as GLP-1 obesity drugs. The study found coupon use by commercial insurance holders on obesity drugs dropped from 54.6% of prescriptions in 2017 to only 2.5% in 2024, though use of the drugs rose.
3 What if you expect high medical costs?
If you have insurance and anticipate meeting your deductible for the year, consider using a coupon. However, your insurer likely won't count the value of the coupon toward your deductible. Only use a coupon if there is no generic option available and you know you'd otherwise hit your deductible.
4 What if you have a plan but low costs?
The answer is almost always: Don't use the coupon.
If the drug is covered by your insurance, using coupons will put you at risk for higher indirect costs. It's also often more advantageous to spend toward your deductible.
Watch out for copay adjustment programs that insurers use to discourage use of coupons. They come in two common forms, Long said.
"Copay accumulators" allow the use of drug coupons up to their full value, but the amount of the coupon won't count toward patients' deductibles or out-of-pocket maximums, making it harder to reach the threshold at which insurers will pitch in on prescriptions and other medical care. It can also mean a patient eventually will pay the full cost of the drug because they haven't yet met their annual deductible.
"Copay maximizers," which also prevent the coupon value from counting toward deductibles, use a third party to adjust patients' copayments over the course of a year to match the amount of the manufacturers' coupons.
5 What if you're on Medicaid or Medicare?
Medicare and Medicaid beneficiaries are prohibited from using manufacturer-sponsored coupons. A federal anti-kickback law makes it illegal to give someone anything of value to influence their decision to purchase something that will ultimately be paid for by a federal healthcare program. The law also prevents remuneration, which includes waiving copays and charging less than fair-market value for a product.
Some states, notably


Would New Jersey’s Proposed $900 Pet Tax Credit Replace the Need for Pet Insurance? | Insurify
Arizona AG Mayes accuses health insurance companies of price fixing
Advisor News
- The missing piece in most retirement plans
- Clients are bringing TikTok insurance advice into advisor meetings
- Embracing a family-centric approach to financial planning
- Family communication: Financial planning’s growing blind spot
- Americans aren’t turning retirement plans into action, LIMRA finds
More Advisor NewsAnnuity News
- Cayman Islands premier to meet with U.S. reinsurance regulators
- Investigation finds deceptive sales, churning of annuities targeting postal workers
- Corebridge annuity sales slip ahead of Equitable marriage
- California teachers settle class-action lawsuit over in-plan annuity fees
- Jackson Financial CEO caps 40-year career with blockbuster Q2
More Annuity NewsHealth/Employee Benefits News
- Healey announces campaign to help residents hold onto their healthcare coverage
- State agency seeks
waiver to reinstate
HIP cost-sharing
- IN NEW ASSAULT ON TRANS YOUTH CARE, TRUMP ADMINISTRATION BARS MEDICAID AND CHIP COVERAGE FOR NECESSARY HEALTH CARE
- PAUL KRUGMAN: US HEALTH CARE IS ALREADY SOCIALIST
- Editorial: Louisianans losing health care coverage
More Health/Employee Benefits NewsLife Insurance News
- LIMRA: Individual life sales continue growth trend in Q2, led by whole life and VUL
- New York Life Awards 20 Golden Futures Scholarships, Expanding Student Support Through Financial Education and Career Development
- Built to Last: Winston-Salem—a quiet industrial powerhouse
- The silver economy ushers in a new era of life insurance growth
- Family communication: Financial planning’s growing blind spot
More Life Insurance News